Cargando…

Timapiprant, a prostaglandin D2 receptor antagonist, ameliorates pathology in a rat Alzheimer’s model

We investigated the relevance of the prostaglandin D2 pathway in Alzheimer’s disease, because prostaglandin D2 is a major prostaglandin in the brain. Thus, its contribution to Alzheimer’s disease merits attention, given the known impact of the prostaglandin E2 pathway in Alzheimer’s disease. We used...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wallace, Charles H, Oliveros, Giovanni, Serrano, Peter A, Rockwell, Patricia, Xie, Lei, Figueiredo-Pereira, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Life Science Alliance LLC 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515385/ https://www.ncbi.nlm.nih.gov/pubmed/36167438 http://dx.doi.org/10.26508/lsa.202201555

Ejemplares similares

Investigation on the use of fused deposition modeling for the production of IR dosage forms containing Timapiprant
por: Uboldi, Marco, et al.
Publicado: (2022)

Neuroinflammation and J2 prostaglandins: linking impairment of the ubiquitin-proteasome pathway and mitochondria to neurodegeneration
por: Figueiredo-Pereira, Maria E., et al.
Publicado: (2015)

Females exhibit higher GluA2 levels and outperform males in active place avoidance despite increased amyloid plaques in TgF344-Alzheimer’s rats
por: Chaudry, Osama, et al.
Publicado: (2022)

Prostaglandin EP2 receptor antagonist ameliorates neuroinflammation in a two-hit mouse model of Alzheimer’s disease
por: Banik, Avijit, et al.
Publicado: (2021)

33886 Deregulation of the LANCL2 Pathway in Alzheimer's Disease
por: Birnbaumria, Emily, et al.
Publicado: (2021)

Prostaglandin D2/J2 signaling pathway in a rat model of neuroinflammation displaying progressive parkinsonian-like pathology: potential novel therapeutic targets
por: Corwin, Chuhyon, et al.
Publicado: (2018)

Thromboxane–prostaglandin receptor antagonist, terutroban, prevents neurovascular events after subarachnoid haemorrhage: a nanoSPECT study in rats
por: Lagier, David, et al.
Publicado: (2019)

Prostaglandin E Receptor 4 Antagonist in Cancer Immunotherapy: Mechanisms of Action
por: Take, Yukinori, et al.
Publicado: (2020)

TRPV4 antagonists ameliorate ventriculomegaly in a rat model of hydrocephalus
por: Hochstetler, Alexandra E., et al.
Publicado: (2020)

Ginsenoside Rg1 ameliorates Alzheimer's disease pathology via restoring mitophagy
por: Wang, Ni, et al.
Publicado: (2023)

Microglial inhibition of neuroprotection by antagonists of the EP1 prostaglandin E2 receptor
por: Carlson, Noel G, et al.
Publicado: (2009)

Grapiprant: an EP4 prostaglandin receptor antagonist and novel therapy for pain and inflammation
por: Kirkby Shaw, Kristin, et al.
Publicado: (2015)

Increased isoprostane and prostaglandin are prominent in neurons in Alzheimer disease
por: Casadesus, Gemma, et al.
Publicado: (2007)

Antiallergic drug desloratadine as a selective antagonist of 5HT(2A) receptor ameliorates pathology of Alzheimer's disease model mice by improving microglial dysfunction
por: Lu, Jian, et al.
Publicado: (2020)

Amelioration of Alzheimer’s disease pathology and cognitive deficits by immunomodulatory agents in animal models of Alzheimer’s disease
por: Martinez, Bridget, et al.
Publicado: (2019)

ADAMTS13 maintains cerebrovascular integrity to ameliorate Alzheimer-like pathology
por: Cao, Yongliang, et al.
Publicado: (2019)

Antihypertensive medications ameliorate Alzheimer's disease pathology by slowing its propagation
por: Affleck, Andrew J., et al.
Publicado: (2020)

Steroidal Antagonists of Progesterone- and Prostaglandin E(1)-Induced Activation of the Cation Channel of Sperm
por: Carlson, Erick J., et al.
Publicado: (2022)

The Computer Simulation of Therapy with the NMDA Antagonist in Excitotoxic Neurodegeneration in an Alzheimer’s Disease-like Pathology
por: Świetlik, Dariusz, et al.
Publicado: (2022)

Inhibition of microsomal prostaglandin E synthase-1 by aminothiazoles decreases prostaglandin E(2) synthesis in vitro and ameliorates experimental periodontitis in vivo
por: Kats, Anna, et al.
Publicado: (2013)

PACAP27 mitigates an age‐dependent hippocampal vulnerability to PGJ2‐induced spatial learning deficits and neuroinflammation in mice
por: Avila, Jorge A., et al.
Publicado: (2019)

Sulfanegen stimulates 3-mercaptopyruvate sulfurtransferase activity and ameliorates Alzheimer's disease pathology and oxidative stress in vivo
por: Rao, Swetha Pavani, et al.
Publicado: (2022)

The severity of NEC is ameliorated by prostaglandin E2 through regulating intestinal microcirculation
por: Mo, Dandan, et al.
Publicado: (2023)

Inhibition of Stat3‐mediated astrogliosis ameliorates pathology in an Alzheimer's disease model
por: Reichenbach, Nicole, et al.
Publicado: (2019)

O-GlcNAcylation ameliorates the pathological manifestations of Alzheimer’s disease by inhibiting necroptosis
por: Park, Jinsu, et al.
Publicado: (2021)

GENETIC AND PHARMACOLOGIC PROTEASOME AUGMENTATION AMELIORATES ALZHEIMER’S-LIKE PATHOLOGY IN MICE AND FLIES
por: Pickering, Andrew
Publicado: (2022)

Retraction: ADAMTS13 maintains cerebrovascular integrity to ameliorate Alzheimer-like pathology
Publicado: (2023)

A selective antagonist of prostaglandin E receptor subtype 4 attenuates abdominal aortic aneurysm
por: Mamun, Al, et al.
Publicado: (2018)

Inhibitory effects of a selective prostaglandin E2 receptor antagonist RQ-15986 on inflammation-related colon tumorigenesis in APC-mutant rats
por: Shirakami, Yohei, et al.
Publicado: (2021)

Upregulation of Prickle2 Ameliorates Alzheimer’s Disease-Like Pathology in a Transgenic Mouse Model of Alzheimer’s Disease
por: Sun, Fengxian, et al.
Publicado: (2020)

Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer’s disease model
por: Zhong, Li, et al.
Publicado: (2019)

Prostaglandins and prostaglandin receptor antagonism in migraine
por: Antonova, M
Publicado: (2013)

Lactones in the Synthesis of Prostaglandins and Prostaglandin Analogs
por: Tănase, Constantin, et al.
Publicado: (2021)

Loganin substantially ameliorates molecular deficits, pathologies and cognitive impairment in a mouse model of Alzheimer’s disease
por: Nie, Lulin, et al.
Publicado: (2021)

Intermittent hypoxia therapy ameliorates beta-amyloid pathology via TFEB-mediated autophagy in murine Alzheimer's disease
por: Wang, Xueting, et al.
Publicado: (2023)

Inhibition of microsomal prostaglandin E synthase-1 ameliorates acute lung injury in mice
por: Gurusamy, Malarvizhi, et al.
Publicado: (2021)

Intraventricular infusion of clusterin ameliorated cognition and pathology in Tg6799 model of Alzheimer’s disease
por: Qi, Xue-Mei, et al.
Publicado: (2018)

1950 MHz Electromagnetic Fields Ameliorate Aβ Pathology in Alzheimer’s Disease Mice
por: Jeong, Ye Ji, et al.
Publicado: (2015)

Phosphodiesterase 5 inhibitor mirodenafil ameliorates Alzheimer-like pathology and symptoms by multimodal actions
por: Kang, Byung Woo, et al.
Publicado: (2022)

Subchronic infusion of the product of inflammation prostaglandin J2 models sporadic Parkinson's disease in mice
por: Pierre, Sha-Ron, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_9iimfkolqf0sk87ditstg3dpls